X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Middle East and South Asia

PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season

Content Team by Content Team
28th August 2020
in Middle East and South Asia, Press Statements
PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

PharmaSources, an international B2B trade portal for the pharmaceutical verticals, is launching the virtual event CPhI & P-MEC China E-Trade Season from August to December 2020. Consisting of the three sessions “Top API Exporters & Products”, “Popular Natural Extracts for Health and Pharma” and “P-MEC China Webinar: Russia Pharmaceutical Manufacturing and Machinery”, the E-Trade Season is to facilitate digital sourcing solutions, learning opportunities and business connections for global pharmaceutical practitioners.

The Chinese pharmaceutical market is estimated to reach $161.8 billion by 2023 and take a 30% share of the global market. Among all the industry segments, APIs, natural extracts and pharma machinery are the most export-oriented, creating the export value of 33.68 billion, 2.37 billion and 242.29 million respectively in year 2019.

With the outbreak of COVID-19, the Chinese pharma industry is facing more challenges and uncertainties, including production slowdowns and barred exporting supply chains. The cancellation or postponement of the major pharmaceutical events has also lessened the opportunities of face-to-face communication and exchanges within the pharma community.

“COVID-19 has changed the environment for export trade, and we are launching our event against the eventful time.” commented Zing Zhou, Senior Director of PharmaSources, “This E-Trade Season, spanning the pharma sectors of APIs, natural extracts and machinery, will cast massive exposure of the local pharma manufacturers instantly towards the global markets, as well as broaden the souring choices for international buyers.”

CPhI China Top API Exporters & Products
– 24-28 August 2020

This session will bring together the 100 cream-of-the-crop API exporters of China and showcase the most popular exporting products. International buyers will be able to raise inquiries directly to the top suppliers through a simple click. Through the Video Meeting function, on-demand online meetings will be hosted for supplier and buyer to meet and talk on 1-to-1 basis. A free-downloadable industry annual review will be presented to give strategically valuable references for global pharma professionals and companies.

Popular Natural Extracts for Health and Pharma
– 21-25 September 2020

The natural extract session will present 350 quality exporting suppliers with their key products for the usage in both the health and pharma sectors. Multiple live webinars on heated topics tailored for overseas markets will be on live streaming with free access for viewers. The key players from China will be introducing their latest innovations on products and technologies and interact with the audiences for deeper exchanges.

P-MEC China Webinar – Russia Pharmaceutical Manufacturing and Machinery
– 19 October 2020

P-MEC China is going to organize the live webinar on the topic of pharmaceutical manufacturing and machinery in China, Russia and CIS markets on 19th October. The webinar will build a learning and networking platform between professionals in China, Russian and CIS markets and contribute to the advancement of the pharmaceutical manufacturing technology and machinery community connection. The live and interactive webinar is FREE for anyone to register and attend.

About PharmaSources

Rolled out in 2010 as an online trade platform serving the pharmaceutical industry, EN-CPhI.CN has been re-named and rebranded to PharmaSources after 10 years driving industry development. PharmaSources connects international pharma buyers and suppliers, promoting trade and development across the industry. The B2B platform features over 8,500 suppliers and 3,600,000 products in 30 major categories spanning the entire pharma supply chain and delivers services to over 90,000 active members across 211 countries and regions.

Previous Post

Patent awarded for Concarlo-developed therapeutic to tackle treatment-resistant breast cancer

Next Post

PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Pharma Advancement Banner
Press Statements

Welcome to the Inaugural Operationalize: Expanded Access Programs Summit West

27th June 2025
Next Post
PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products

PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In